IA
CLBT icon

IFP Advisors’s Cellebrite CLBT Stock Holding History

IFP Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Hold
1,000
– – ﹤0.01% 3167
2026
Q1 		$13.8K Hold
1,000
– – ﹤0.01% 2992
2025
Q4 		$18K Hold
1,000
– – ﹤0.01% 2764
2025
Q3 		$18.5K Hold
1,000
– – ﹤0.01% 2614
2025
Q2 		$16K Hold
1,000
– – ﹤0.01% 2665
2025
Q1 		$19.4K Buy
+1,000
New +$21K ﹤0.01% 2294

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

IFP Advisors's CLBT Position: Q2 2026 in Review

IFP Advisors held its Cellebrite (CLBT) position steady in Q2 2026 at 1,000 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3167.

IFP Advisors first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $19.4K in Q1 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • IFP Advisors held 1,000 shares of Cellebrite worth $14.6K as of Q2 2026.
  • IFP Advisors left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3167 holding.
  • IFP Advisors first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
  • IFP Advisors's Cellebrite position peaked at $19.4K in Q1 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.